Results
|
|
3641.
|
Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study. [electronic resource] by
- Bennett, J M
- Young, M S
- Liesveld, J L
- Paietta, E
- Miller, K B
- Lazarus, H M
- Marsh, R D
- Friedenberg, W R
- Saba, H T
- Hayes, F A
- Dewald, G W
- Hiddemann, W
- Rowe, J M
Producer: 20010726
In:
American journal of hematology vol. 66
Availability: No items available.
|
|
|
3642.
|
|
|
|
3643.
|
|
|
|
3644.
|
|
|
|
3645.
|
|
|
|
3646.
|
|
|
|
3647.
|
|
|
|
3648.
|
|
|
|
3649.
|
|
|
|
3650.
|
|
|
|
3651.
|
|
|
|
3652.
|
|
|
|
3653.
|
|
|
|
3654.
|
|
|
|
3655.
|
Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals. [electronic resource] by
- Waldthaler, Christian
- Stauder, Reinhard
- Schnallinger, Michael
- Schreieck, Stephan
- Hager, Judith
- Oexle, Horst
- Zangerl, Günther
- Verdorfer, Irmgard
- Zabernigg, August
- Gastl, Günther
- Fiegl, Michael
Producer: 20120103
In:
Wiener klinische Wochenschrift vol. 123
Availability: No items available.
|
|
|
3656.
|
|
|
|
3657.
|
|
|
|
3658.
|
|
|
|
3659.
|
|
|
|
3660.
|
|